These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 15801331)
1. Impact of a soluble phospholipase A2 inhibitor on inhaled allergen challenge in subjects with asthma. Bowton DL; Dmitrienko AA; Israel E; Zeiher BG; Sides GD J Asthma; 2005 Feb; 42(1):65-71. PubMed ID: 15801331 [TBL] [Abstract][Full Text] [Related]
2. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses. Pizzichini MM; Kidney JC; Wong BJ; Morris MM; Efthimiadis A; Dolovich J; Hargreave FE Eur Respir J; 1996 Mar; 9(3):449-55. PubMed ID: 8730003 [TBL] [Abstract][Full Text] [Related]
3. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial. Beeh KM; Beier J; Meyer M; Buhl R; Zahlten R; Wolff G Pulm Pharmacol Ther; 2006; 19(4):233-41. PubMed ID: 16140027 [TBL] [Abstract][Full Text] [Related]
4. A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma. Swystun V; Green FHY; Dennis JH; Rampakakis E; Lalli G; Fadayomi M; Chiu A; Shrestha G; El Shahat SG; Nelson DE; El Mays TY; Pieron CA; Leigh R Trials; 2018 Jun; 19(1):321. PubMed ID: 29914544 [TBL] [Abstract][Full Text] [Related]
5. Inhaled synthetic surfactant abolishes the early allergen-induced response in asthma. Babu KS; Woodcock DA; Smith SE; Staniforth JN; Holgate ST; Conway JH Eur Respir J; 2003 Jun; 21(6):1046-9. PubMed ID: 12797502 [TBL] [Abstract][Full Text] [Related]
6. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. Diamant Z; Timmers MC; van der Veen H; Friedman BS; De Smet M; Depré M; Hilliard D; Bel EH; Sterk PJ J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):42-51. PubMed ID: 7822663 [TBL] [Abstract][Full Text] [Related]
7. Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma. Diamant Z; Timmers MC; van der Veen H; Page CP; van der Meer FJ; Sterk PJ Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1790-5. PubMed ID: 8665036 [TBL] [Abstract][Full Text] [Related]
8. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma. Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048 [TBL] [Abstract][Full Text] [Related]
9. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Taylor IK; O'Shaughnessy KM; Fuller RW; Dollery CT Lancet; 1991 Mar; 337(8743):690-4. PubMed ID: 1672176 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005. Dahlén B; Kumlin M; Ihre E; Zetterström O; Dahlén SE Thorax; 1997 Apr; 52(4):342-7. PubMed ID: 9196517 [TBL] [Abstract][Full Text] [Related]
11. Effects of JNJ-40929837, a leukotriene A4 hydrolase inhibitor, in a bronchial allergen challenge model of asthma. Barchuk W; Lambert J; Fuhr R; Jiang JZ; Bertelsen K; Fourie A; Liu X; Silkoff PE; Barnathan ES; Thurmond R Pulm Pharmacol Ther; 2014 Oct; 29(1):15-23. PubMed ID: 25018015 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of fluticasone and montelukast on allergen-induced asthma. Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933 [TBL] [Abstract][Full Text] [Related]
13. Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005. Hamilton AL; Watson RM; Wyile G; O'Byrne PM Thorax; 1997 Apr; 52(4):348-54. PubMed ID: 9196518 [TBL] [Abstract][Full Text] [Related]
14. Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics. Bowton DL; Seeds MC; Fasano MB; Goldsmith B; Bass DA Am J Respir Crit Care Med; 1997 Feb; 155(2):421-5. PubMed ID: 9032172 [TBL] [Abstract][Full Text] [Related]
15. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma. Diamant Z; Grootendorst DC; Veselic-Charvat M; Timmers MC; De Smet M; Leff JA; Seidenberg BC; Zwinderman AH; Peszek I; Sterk PJ Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701 [TBL] [Abstract][Full Text] [Related]
16. Effect of oral and inhaled cetirizine in allergen induced bronchoconstriction. Rafferty P; Ghosh SK; de Vos C; Patel KR Clin Exp Allergy; 1993 Jun; 23(6):528-31. PubMed ID: 8369980 [TBL] [Abstract][Full Text] [Related]